2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33082357 | Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer. | 2020 Oct 20 | 3 |
| 2 | 31585811 | IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer. | 2019 Dec | 7 |